Alcohol and drug abuse treatment led Mountville Medicaid payments in 2024 at $10.6 million

Dr. Mehmet Oz CMS Administrator
Dr. Mehmet Oz CMS Administrator
0Comments

In 2024, Medicaid providers in Mountville submitted $10,575,501 in claims for services within the Alcohol and Drug Abuse Treatment category, U.S. Department of Health and Human Services Medicaid Provider Spending data show. This total represents a 4.3% uptick from 2023, when the amount for the same service category reached $10,140,770.

Medicaid, a public health insurance program managed by the states and backed by federal and state dollars, provides coverage for low-income residents, older adults, children, and individuals with disabilities, making it one of the most significant segments of health care spending in the U.S.

Since Medicaid expenditures are funded by taxpayers, shifts in billing reveal changes in how local health funds are being used throughout the area.

The “Alcohol and Drug Abuse Treatment” category encompasses services classified by type of care delivered, grouped according to standardized HCPCS and CPT codes. For this report, each billing code was allotted to a single service type based on consistent digits and code prefixes, allowing for reliable trend tracking and preventing duplicate counts.

Though Medicaid costs went up among several categories, Alcohol and Drug Abuse Treatment was Mountville’s top category for Medicaid payment totals in 2024.

Statewide in Pennsylvania, Alcohol and Drug Abuse Treatment services also ranked first for total Medicaid payments in 2024.

Between 2019 and 2024, Mountville’s Medicaid payments for Alcohol and Drug Abuse Treatment climbed by $9,448,567, equating to an 838.4% increase. The rate of growth was especially pronounced during periods such as 2021 and 2023, which showed substantial annual increases.

While the category’s Medicaid funding was distributed across various city areas, most payments came from a select few ZIP codes. In 2024, ZIP code 17554 alone accounted for $10,575,500 of the total, making up 100% of Mountville’s Medicaid payments for Alcohol and Drug Abuse Treatment that year.

Within Alcohol and Drug Abuse Treatment, the payments were focused within a small set of billing codes.

Comparatively, the Alcohol and Drug Abuse Treatment category in Mountville grew by 4.3% from 2023 to 2024, outpacing the 3.3% overall change recorded for all categories of Medicaid claims throughout the city in the same period.

The Centers for Medicare & Medicaid Services reported that total federal and state Medicaid costs hit about $871.7 billion for fiscal 2023, making up around 18% of national health spending, sharply higher than the roughly $613.5 billion recorded in 2019 before the COVID-19 emergency.

This surge reflects close to 40% growth in just a few years, with main contributors being increased enrollment and service use during and following the pandemic.

Recent federal budget initiatives under the Trump administration involved major proposals aiming to limit federal Medicaid support and reshape the system. The “One Big Beautiful Bill Act,” which became law in 2025, is set to decrease federal Medicaid spending by more than $1 trillion in the next decade and introduces measures including work requirements and more cost-sharing from recipients, which may curb coverage and financial resources for some. As a result, there could be greater financial responsibility shifted to states and restricted federal funding growth even as Medicaid remains vital to tens of millions nationwide.

Medicaid Payments Tied to Alcohol and Drug Abuse Treatment in Mountville, Pennsylvania Over Five Years

Year Total Medicaid Payments % Change From Previous Year
2020 $1,126,934
2021 $5,071,323 350%
2022 $6,346,261 25.1%
2023 $10,140,770 59.8%
2024 $10,575,500 4.3%
Top Categories by Medicaid Payments in Mountville, Pennsylvania, 2024

Rank Category Medicaid Payments Share of City Total
1 Alcohol and Drug Abuse Treatment $10,575,500 60.9%
2 Medicine Services and Procedures $3,792,646 21.8%
3 National Codes Established for State Medicaid Agencies $1,470,316 8.5%
4 Evaluation and Management $873,950 5%
5 Durable Medical Equipment $484,363 2.8%
6 Medical And Surgical Supplies $154,966 0.9%
7 Durable medical equipment (DME) Medicare administrative contractors (MACs) $8,556 <0.1%
Top 20 HCPCS Codes Within the Alcohol and Drug Abuse Treatment Category in Mountville, Pennsylvania, 2024

HCPCS Code Description Medicaid Payments Claims
H0036 Comm psy face-face per 15min $2,758,125 12
H2030 Mh clubhouse svc, per 15 min $2,598,054 12
H0004 Alcohol and/or drug services $1,829,657 12
H2034 A/d halfway house, per diem $1,664,347 11
H0035 Mh partial hosp tx under 24h $1,486,212 12
H0034 Med trng & support per 15min $123,310 12
H0038 Self-help/peer svc per 15min $84,861 12
H2021 Com wrap-around sv, 15 min $30,932 3

Note: HCPCS codes are shown for context within the category. Category totals and rankings in this article are based on standardized service groupings rather than individual billing codes.

Information in this article was obtained from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The source data can be found here.



Related

Sean R. Keveney J.D., Chief Counsel of FDA

FDA cites Daud’s Specialties, LLC in Lancaster for 4 violations during March 18 inspection

Daud’s Specialties, LLC in Lancaster was inspected by the FDA on March 18 for food standards, labeling, economic factors and foodborne biological hazards, resulting in four violations.

Benjamin D. Moncarz Chief Financial Officer - FDA

Henry Schein, Inc. in Denver receives FDA inspection on April 2

On April 2, the FDA evaluated Henry Schein, Inc. in Denver, focusing on food composition, labeling, and foodborne biological hazards, based on information released on the FDA’s website.

Sridhar Mantha, Acting Chief Information Officer of FDA

FDA inspects Central Pennsylvania Blood Bank in Ephrata on March 11

The Central Pennsylvania Blood Bank in Ephrata was inspected by the FDA on March 11 regarding blood and blood product safety, based on information made available on the FDA’s website.